PD03 - ESAP 2026 Live

Saturday, June 13, 2026

4:30 PM - 6:00 PM CT

Location: Room W178

Faculty(s)

Aled Rees, MD,PhD (he/him/his)

Doctor
Cardiff University
Cardiff, Wales, United Kingdom

Disclosure(s): Diurnal Ltd: Advisory Board (); Immedica Pharma AB: Honorarium Recipient (); Neurocrine Biosciences: Advisory Board (), Contracted Research (Principal Investigators must provide information, even if received by the institution) (), Honorarium Recipient (); Recordati Rare Disease: Advisory Board ()
ES

Elias Spanakis, MD

Associate Professor of Medicine
University of Maryland School of Medicine

Disclosure information not submitted.
Angela Leung, MD, MSc

Associate Professor of Medicine
UCLA David Geffen School of Medicine
Los Angeles, CA, United States

Disclosure information not submitted.
Erik Imel, MD

Professor
Indiana University School of Medicine
Indianapolis, Indiana, United States

Disclosure(s): Amgen Inc.: Advisory Board (), Clinical Trial Investigator (); Calcilytix: Clinical Trial Investigator (); Kyowa Kirin: Advisory Board (), Clinical Trial Investigator (), Consultant (); Neurocrine: Advisory Board (), Clinical Trial Investigator (); UltraGenyx: Advisory Board (), Clinical Trial Investigator (), Consultant ()

Disclosure(s):

Aled Rees, MD,PhD: Diurnal Ltd: Advisory Board (); Immedica Pharma AB: Honorarium Recipient (); Neurocrine Biosciences: Advisory Board (), Contracted Research (Principal Investigators must provide information, even if received by the institution) (), Honorarium Recipient (); Recordati Rare Disease: Advisory Board ()

Erik A. Imel, MD: Amgen Inc.: Advisory Board (), Clinical Trial Investigator (); Calcilytix: Clinical Trial Investigator (); Kyowa Kirin: Advisory Board (), Clinical Trial Investigator (), Consultant (); Neurocrine: Advisory Board (), Clinical Trial Investigator (); UltraGenyx: Advisory Board (), Clinical Trial Investigator (), Consultant ()

Description: This interactive session highlights a diverse set of patient cases from the recent edition of the Endocrine Self-Assessment Program.